MYC, one of the most studied oncogenes [31], is typically overexpressed in variety of malignant tumors such as lung cancer, lymphomas, breast cancer, gastric cancer, and colon cancer and is involved in cell proliferation, differentiation, apoptosis and cell cycle [32–37]. Here, MYC is linked to breast carcinoma.